Interesting that the UK and Europe are specifically mentioned below. I understand they have an old partnership with Abcodia the fourth largest biotech company in the UK that are specialists in biomarkers. Back into dream mode.
As companies in Europe and in the UK started to return to their offices and their laboratories from 1 July 2020, we anticipate progress in some of the ongoing negotiations in the coming months.
- Forums
- ASX - By Stock
- AN1
- Ann: Appendix 4C and Quarterly Activity Report
Ann: Appendix 4C and Quarterly Activity Report, page-16
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable